학술논문
Cryopreserved Versus Non-Cryopreserved Peripheral Blood Haematopoietic Stem Cells for Autologous Stem Cell Transplantation in Multiple Myeloma: A Comparative Analysis from the Chronic Malignancies Working Party of EBMT and WBMT
Document Type
Article
Author
Med Amine, Bekadja; Gras, Luuk; Baaij, Laurien; Koster, Linda; Carpenter, Ben; Nicholson, Emma; Potter, Victoria; Broers, Annoek E.C.; Blaise, Didier; Byrne, Jenny Louise; Huynh, Anne; Burns, David; Reményi, Péter; Collin, Matthew P.; Gribben, John G.; Clay, Jennifer; Tucci, Alessandra; De Las Heras, Natalia; Drozd-Sokolowska, Joanna; Raj, Kavita; Beksac, Meral; Schönland, Stefan; Hayden, Patrick J; Aljurf, Mahmoud Deeb; McLornan, Donal P; Garderet, Laurent; Niederwieser, Dietger
Source
Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p1034-1034, 1p
Subject
Language
ISSN
00064971; 15280020
Abstract
Introduction:Globally, most transplant centres cryopreserve peripheral blood haematopoietic stem cells (PBSC) for use in a subsequent autologous haematopoietic cell transplant (AHCT), utilizing Dimethyl sulfoxide (DMSO) as a cryoprotectant. In contrast, non-vryopreserved PBSC are used in autologous transplants for multiple myeloma (MM) in some countries with more limited resources. We therefor compared standard MM AHCT outcomes between a large transplant centre in Algeria and EBMT registry data.